Clinical and immunological profile of systemic lupus erythematosis with evaluation of disease activity.
Not Applicable
- Conditions
- Health Condition 1: M32- Systemic lupus erythematosus (SLE)
- Registration Number
- CTRI/2021/06/034122
- Lead Sponsor
- DR Manjunath Hande
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients >18-year-old diagnosed as SLE with new ACR and EULAR criteria/ SLICC criteria
Exclusion Criteria
Patient with sepsis/other active infections
Overlap syndromes with other rheumatological diseases
Acute/chronic kidney disease (other than lupus nephritis)
Leukaemia, lymphoma, malignancies
Vasculitis
Acute MI, Acute stroke
Patients on systemic steroids >5mg/day
Uncontrolled diabetes HbA1c > 7%
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method